Call for Abstract

3rd International Conference and Exhibition on Clinical & Cellular Immunology, will be organized around the theme “From Basic Immune Understanding to Clinical Breakthroughs ”

Immunology Summit-2014 is comprised of 20 tracks and 119 sessions designed to offer comprehensive sessions that address current issues in Immunology Summit-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Advances clinical immunology
  • Track 1-2Mechanisms in clinical immunology
  • Track 1-3Allergy & clinical immunology
  • Track 1-4Endotypes & phenotypes in chronic rhinosinusitis
  • Track 1-5Immunological clinical trials
  • Track 1-6Oral immunotherapy
  • Track 1-7Clinical manifestation and IgE recognition
  • Track 1-8Clinical outcomes in hematopopoietic stem cell transplantation
  • Track 1-9Clinical obstructive pulmonary diseases
  • Track 2-1B-cell and T-cell receptors
  • Track 2-2Extracellular acidosis
  • Track 2-3Advances in cellular immunology
  • Track 2-4Pattern recognition receptors and cellular encapsulation
  • Track 2-5Cellular senescence and cancer in aging
  • Track 2-6Vaccination-induced cellular immunity
  • Track 2-7Cellular automata and agent based models
  • Track 2-8Cellular antioxidant activities
  • Track 3-1Autoimmune diseases: Organ and tissue
  • Track 3-2Inflammatory bowel disease
  • Track 3-3Major histocompatibility complex classes
  • Track 3-4Gastro intestinal autoimmunity, skin and autoimmunity
  • Track 3-5Systemic lupus erythematosus
  • Track 3-6Infection and autoimmunity, and metabolic disorders
  • Track 3-7Multiple sclerosis, and mislenious autoimmune diseases
  • Track 4-1Neutrophils and macrophages in cancer/tumor
  • Track 4-2Immune markers in cancer and tumor
  • Track 4-3Anti-cancer/tumor immunity
  • Track 4-4Tumor angiogenesis
  • Track 4-5Engineered mouse models in cancer
  • Track 4-6Advanced technology in cancer/tumor immunology
  • Track 4-7Cancer therapy and clinical cancer research
  • Track 5-1Bacterial vaccines
  • Track 5-2Viral vaccines
  • Track 5-3Parasite vaccines
  • Track 5-4Cancer vaccines
  • Track 5-5Autoimmune disease vaccines
  • Track 5-6Allergy vaccines
  • Track 5-7Vaccine safety and regulation
  • Track 6-1Dermatophagoides pteronyssinus and immunotherapy
  • Track 6-2Efficacy and safety in immunotherapy
  • Track 6-3Sublingual immunotherapy
  • Track 6-4Cancer immunotherapy
  • Track 7-1Influenza virus and immune system
  • Track 7-2HIV & AIDS
  • Track 7-3Viral infections
  • Track 7-4Bacterial infections
  • Track 7-5Viral-bacterial confection
  • Track 7-6Inflammatory infectious diseases
  • Track 7-7Infectious diseases and immune system regulation
  • Track 8-1Autoantibodies , Auto-antigens and vaccine antigens in plant cells
  • Track 8-2Nucleic acid associated autoantigens
  • Track 8-3Intracellular autoantigens
  • Track 8-4Tumor antigens & recombinant autoantigens
  • Track 8-5Autoantibody explosion
  • Track 8-6Cellular & retinal auto antigens
  • Track 8-7Auto-antibodies in cancer patients
  • Track 8-8Factor-h autoantibody assay
  • Track 8-9Immunoglobulin g a & serum autoantibodies
  • Track 9-1Mutine autoimmune arthritis
  • Track 9-2Autoimmune myasthenia gravis
  • Track 9-3Inflammatory arthritis
  • Track 9-4Tissue regeneration in autoimmunity
  • Track 9-5Advances in autoimmunity
  • Track 10-1Hypersensitivity, asthma & allergic responses
  • Track 10-2Mast cell in allergic inflations
  • Track 10-3Allergy immunotherapy
  • Track 10-4Allergic disease models
  • Track 10-5Advances in allergy research
  • Track 10-6Food allergy
  • Track 11-1Advanced research in antigen sampling & processing
  • Track 11-2Circulatory antigen processing
  • Track 11-3Viral interferences
  • Track 11-4Tap independent processing pathways
  • Track 11-5Humoral and cellular immune responses
  • Track 11-6Antigen processing through macroautophagy
  • Track 12-1T-cell derived B-cell growth factor
  • Track 12-2T cell-B cell collaboration
  • Track 12-3Invitro invivo studies
  • Track 12-4Cell culture models for t-cell mediated b-cell activation
  • Track 12-5B and T cell homeostasis
  • Track 12-6T-cells and B-cells in multiple sclerosis
  • Track 13-1Neuro-immune algorithm
  • Track 13-2Neural stem cell transplantation
  • Track 13-3Neuro immuno endocrine system
  • Track 13-4Interferon signaling and neuro immunology
  • Track 13-5Experimental neuro immunology
  • Track 14-1Current trends in reproductive immunology
  • Track 14-2Invitro fertilization reproductive immunology
  • Track 14-3Clinical practices in reproductive immunology
  • Track 14-4Avian reproductive immune system
  • Track 14-5Autoimmune diseases and reproductive immunology
  • Track 14-6Procine reproductive and respiratory syndrome
  • Track 15-1Costimmulatory pathways in multiple sclerosis
  • Track 15-2T-cell costimulation
  • Track 15-3CD27,CD70, CD40, CD40L costimmulatory pathways
  • Track 15-4PD1, PD -L1 pathway
  • Track 15-5Co-inhibitory pathways
  • Track 15-6Novel costimulatory pathways
  • Track 16-1Advanced diagnostic tools
  • Track 16-2Diagnostic biomarkers
  • Track 16-3Diagnostic and therapeutic role of micro RNA in immunediseases
  • Track 16-4Diagnostic immunology of HIV-1 virus
  • Track 17-1Advanced technology for immunology
  • Track 17-2DNA probe technology
  • Track 17-3Antigen arrays in T-cell immunology
  • Track 17-4Automated high-throughput assay
  • Track 17-5Live cell and single molecule imaging experiments
  • Track 17-6Spectral flow cytometer
  • Track 17-7Hybridoma technologies
  • Track 17-8Novel cell analyzer
  • Track 18-1Immune epitope predictions
  • Track 18-2Immunological omics data analysis
  • Track 18-3Literature mining and immunology
  • Track 18-4Vaccine informatics
  • Track 18-5Immunological data intergration
  • Track 19-1Degenerative arthropathies
  • Track 19-2Inflammatory arthropathies
  • Track 19-3Systemic conditions and connective tissue diseases
  • Track 19-4Soft Tissue Rheumatism